Term: exatecan mesylate Pronunciation: (EK-suh-TEE-kan MEH-zih-layt) May 24, 2024October 7, 2025 Description: An anticancer drug that is a type of topoisomerase inhibitor. Also called DX-8951f. Related Posts:A phase III study (EMBRACE) of eribulin mesylate…